Search results for "type 2"

showing 10 items of 1034 documents

Are glucose profiles well-controlled within the targets recommended by the international diabetes federation in type 2 diabetes? : a meta-analysis of…

2018

AIMS: To assess continuous glucose monitoring (CGM) derived intra-day glucose profiles using global guideline for type 2 diabetes recommended by the International Diabetes Federation (IDF). METHODS: The Cochrane Library, MEDLINE, PubMed, CINAHL and Science Direct were searched to identify observational studies reporting intra-day glucose profiles using CGM in people with type 2 diabetes on any anti-diabetes agents. Overall and subgroup analyses were conducted to summarise mean differences between reported glucose profiles (fasting glucose, pre-meal glucose, postprandial glucose and post-meal glucose spike/excursion) and the IDF targets. RESULTS: Twelve observational studies totalling 731 pe…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismSubgroup analysisType 2 diabetesHypoglycemiaCochrane LibraryGastroenterology03 medical and health sciences0302 clinical medicineEndocrinologyRA0421Diabetes mellitusInternal medicineInternal MedicinemedicineHumans030212 general & internal medicineAgedbusiness.industryBlood Glucose Self-Monitoringdigestive oral and skin physiologynutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseasePostprandialDiabetes Mellitus Type 2Meta-analysisFemaleHemoglobinbusiness
researchProduct

Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabet…

2012

Background: The aim of this study was to investigate early morphological and functional pathology in the retinal micro-circulation in patients with insulin resistance and/or type 2 diabetes mellitus (T2DM). Methods: Fifty-four subjects, without features of retinopathy under ophthalmological investigation, were recruited for study participation and were classifed into three study groups according to their metabolic staging: (1) Group C comprised nondiabetic, insulin-sensitive subjects with a BMI <28kg/m2; (2) Group IR comprised nondiabetic, insulin-resistant, obese subjects with a BMI ≥28 kg/m2; and (3) Group DM comprised patients with manifested T2DM. Retinal microvascular blood flow was…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineeringPilot Projectschemistry.chemical_compoundInsulin resistanceRetinal DiseasesInternal medicineOphthalmologyDiabetes mellitusInternal MedicineLaser-Doppler FlowmetryMedicineHumansObesityFluorescein AngiographyAgedDiabetic Retinopathymedicine.diagnostic_testbusiness.industryType 2 Diabetes MellitusRetinal VesselsRetinalBlood flowLaser Doppler velocimetryMiddle Agedmedicine.diseaseFluorescein angiographyEndocrinologyCross-Sectional StudiesEarly DiagnosischemistryDiabetes Mellitus Type 2Regional Blood FlowFemaleOriginal ArticleInsulin ResistancebusinessRetinopathyJournal of diabetes science and technology
researchProduct

Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study

2014

Abstract Context: Liraglutide is a glucagon-like peptide-1 analog and glucose-lowering agent whose effects on cardiovascular risk markers have not been fully elucidated. Objective: We evaluated the effect of liraglutide on markers of oxidative stress, heme oxygenase-1 (HO-1), and plasma ghrelin levels in patients with type-2 diabetes mellitus (T2DM). Design and Setting: A prospective pilot study of 2 months' duration has been performed at the Unit of Diabetes and Cardiovascular Prevention at University of Palermo, Italy. Patients and Intervention(s): Twenty subjects with T2DM (10 men and 10 women; mean age: 57 ± 13 y) were treated with liraglutide sc (0.6 mg/d for 2 wk, followed by 1.2 mg/d…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolismContext (language use)Pilot ProjectsType 2 diabetes030204 cardiovascular system & hematologymedicine.disease_causeBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyGlucagon-Like Peptide 1Internal medicineDiabetes mellitusMedicineHumansHypoglycemic AgentsProspective StudiesAgedbusiness.industryLiraglutideBiochemistry (medical)Liraglutide Heme oxygenase Lipid peroxidation Ghrelin Type-2 diabetesOriginal ArticlesLiraglutideMiddle Agedmedicine.diseaseGhrelinMetformin3. Good healthMetforminOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2GhrelinDrug Therapy CombinationFemaleGlycated hemoglobinbusinessOxidative stressHeme Oxygenase-1medicine.drug
researchProduct

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis

2015

Aim Non-alcoholic fatty liver disease (NAFLD) is commonly associated with Type 2 diabetes. Recently, it has been suggested that NAFLD is also frequently associated with Type 1 diabetes and diabetic complications. In this study, we set out to determine whether Type 1 diabetes was associated with liver fat content measured using magnetic resonance imaging. Methods One hundred and twenty-eight patients with Type 1 diabetes, 264 patients with Type 2 diabetes and 67 participants without diabetes were included in this study. Hepatic steatosis was defined as a liver fat content > 5.5%. Results People with Type 1 diabetes and controls were similar for age and BMI. Liver fat content was significantl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGastroenterologyBody Mass IndexEndocrinologyNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineDiabetes mellitusPrevalenceInternal MedicineHumansMass ScreeningMedicineObesityProspective StudiesProspective cohort studyMass screeningAgedType 1 diabetesbusiness.industryFatty liverAge FactorsMiddle AgedOverweightmedicine.diseaseMagnetic Resonance ImagingDiabetes Mellitus Type 1Diabetes Mellitus Type 2LiverIntima-media thicknessFemaleFranceSteatosisbusinessBody mass indexDiabetic Medicine
researchProduct

The impact of coexistent diabetes on the prevalence of coronary heart disease.

1997

Abstract The increased risk of developing cardiovascular disease in diabetic population has been well documented, but the prevalent mechanism of this susceptibility is still only partly explained. We compared the impact of diabetes on ischemic heart disease in patients hospitalized in a public general hospital over a 10-year period. The prevalence of coronary heart disease (CHD) was consistently higher among diabetic population [namely, among non-insulin-dependent diabetes mellitus (NIDDM) patients] when compared with the nondiabetic population. The prevalence was similar in both genders, increasing with age, and was independent from body-mass index, history of smoking, metabolic control, o…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationCoronary DiseaseDiseaseMedical RecordsImpaired glucose toleranceEndocrinologyAge DistributionInternal medicineDiabetes mellitusGlucose IntoleranceInternal MedicinemedicinePrevalenceHumansRisk factoreducationAgedRetrospective Studieseducation.field_of_studyFramingham Risk Scorebusiness.industryVascular diseaseMiddle Agedmedicine.diseaseBlood pressureEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2ItalyCardiologyFemalebusinessDiabetic AngiopathiesJournal of diabetes and its complications
researchProduct

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease

2018

OBJECTIVE The effect of pentoxifylline on Klotho levels in patients with type 2 diabetes mellitus with chronic kidney disease (CKD) was assessed in a post hoc analysis of the Pentoxifylline for Renoprotection in Diabetic Nephropathy (PREDIAN) trial. RESEARCH DESIGN AND METHODS Circulating and urinary tumor necrosis factor-α (TNF-α) and Klotho were measured before and after 1 year of pentoxifylline. The effect on Klotho expression was assessed in cultured renal tubular cells. RESULTS Pentoxifylline administration resulted in decreased serum and urinary TNF-α, whereas serum and urinary Klotho increased significantly. Changes in urinary Klotho, urinary TNF-α, and phosphorus were associated wi…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismUrinary system030232 urology & nephrologyRenal function030204 cardiovascular system & hematologyKidneyurologic and male genital diseasesPentoxifyllineDiabetic nephropathyMice03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineAlbuminuriaAnimalsHumansMedicineDiabetic NephropathiesPentoxifyllineRenal Insufficiency ChronicKlotho ProteinsKlothoCells CulturedAgedGlucuronidaseAdvanced and Specialized NursingTumor Necrosis Factor-alphabusiness.industryKidney metabolismMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsKidney TubulesEndocrinologyDiabetes Mellitus Type 2AlbuminuriaFemalemedicine.symptombusinessFollow-Up StudiesGlomerular Filtration RateKidney diseasemedicine.drugDiabetes Care
researchProduct

Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus.

2017

Aims To determine key worries about hypoglycaemia among insulin-using adults with Type 2 diabetes using a focus group approach. Methods Thirteen focus groups were conducted in three diabetes outpatient care units and one peer support group was set up, in Germany. A total of 64 insulin-dependent adults with Type 2 diabetes (36.5% women, mean age 65.2 ± 11.0 years) discussed their worries about hypoglycaemia. The qualitative results were assigned into thematic categories using a bottom-up coding procedure. Participants completed the Hypoglycaemia Fear Survey and demographic measures were recorded. The results of the Hypoglycaemia Fear Survey were contrasted with the focus group findings to ev…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismType 2 diabetesPeer support03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeAmbulatory careDiabetes mellitusGermanyInternal MedicinemedicineHumansHypoglycemic Agents030212 general & internal medicinePsychiatrymedia_commonAgedbusiness.industryType 2 Diabetes MellitusFearAwarenessFocus GroupsMiddle Agedmedicine.diseaseFocus groupHypoglycemiaSelf EfficacyDiabetes Mellitus Type 2Socioeconomic FactorsQuality of LifeFemaleWorrybusinessDiabetic medicine : a journal of the British Diabetic Association
researchProduct

Altered glutathione system is associated with the presence of distal symmetric peripheral polyneuropathy in type 2 diabetic subjects.

2015

Abstract Distal symmetric peripheral polyneuropathy (DSPN) is a highly prevalent complication of diabetes. However, underlying pathophysiological mechanisms are multiple and not well understood. The aim of our study was to analyze the oxidative stress levels in circulating mononuclear cells by measuring the glutathione system, malondialdehyde and oxidized-LDL, in 60 type 2 diabetic patients from a well-characterized cohort of 196 type 2 diabetic patients. Using a nested case–control design, we studied 30 type 2 diabetic patients with distal symmetric polyneuropathy and 30 diabetic controls without this complication, according to the Neuropathy Disability Score. We have found that diabetic p…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.disease_causePeripheral blood mononuclear cellRisk AssessmentSeverity of Illness IndexAntioxidantschemistry.chemical_compoundEndocrinologyDiabetic NeuropathiesInternal medicineDiabetes mellitusMalondialdehydeInternal MedicineMedicineHumansAgedChi-Square Distributionbusiness.industryIncidenceType 2 Diabetes MellitusGlutathioneMiddle AgedMalondialdehydemedicine.diseasePrognosisGlutathionePathophysiologyOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Case-Control StudiesFemalebusinessComplicationOxidative stressJournal of diabetes and its complications
researchProduct

Serum levels of type III procollagen peptide in diabetes mellitus.

1989

Serum levels of type III procollagen peptide (P-III-P) were investigated in 19 patients with type 1 (insulin-dependent) and in 48 (25 orally treated, 23 insulinized) patients with type 2 (non insulin-dependent) diabetes mellitus. Among patients with type 2 diabetes, 16 orally treated and 14 insulin-treated subjects had macrovascular complications. P-III-P levels were not correlated with the duration of diabetes and with glucose control, nor were there any significant sex and age differences in the levels. P-III-P values were significantly higher in the sera of insulin-treated non insulin-dependent diabetic patients with macroangiopathy. These high values (18.5 +/- 10.8 ng/ml) were in contra…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryType 2 diabetesBiochemistryPathogenesisEndocrinologyInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansSensitizationPancreatic hormoneAgedbusiness.industryInsulinBiochemistry (medical)RadioimmunoassayGeneral MedicineMiddle Agedmedicine.diseaseProcollagen peptidasemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2FemalebusinessProcollagenHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
researchProduct

Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy

1998

Between 1988 and 1992, 565 type 2 diabetic patients were examined for nephropathy and diabetes-associated diseases during hospital treatment. Stages of nephropathy were defined as no clinical sign of nephropathy (N = 280), microalbuminuria (N = 38), overt proteinuria (N = 105), impaired renal function (N = 55), and chronic dialysis therapy (N = 87). In dialyzed patients, HbA1c averaged 6.8%, and, in the other groups, HbA1c was between 7.6% and 8.3% (normal range, 3.8%-6.1%). Cataract was not associated with the severity of nephropathy. Stroke was most common in the stage of renal insufficiency (34%). The following complications, as found in medical history or as current event, showed a sign…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMyocardial InfarctionBlood PressureGastroenterologyNephropathyCohort StudiesDiabetic nephropathyEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansCarotid StenosisDiabetic NephropathiesRenal replacement therapyAgedDiabetic RetinopathyProteinuriabusiness.industryMiddle Agedmedicine.diseaseSurgeryRenal Replacement TherapyCerebrovascular DisordersProteinuriaDiabetes Mellitus Type 2HypertensionAlbuminuriaFemaleHypertrophy Left VentricularMicroalbuminuriaMorbiditymedicine.symptombusinessKidney diseaseJournal of Diabetes and its Complications
researchProduct